Evidence map›Paper›PMID 41313434›Full record

ArticleJournal of neurology2025

Characterization of novel CASQ1 variants in two families with unusual phenotypic features.

Milla Laarne, Manu Jokela, Fang Zhao, Sanna Huovinen, Cornelia Kornblum, Jens Reimann, Mridul Johari, Anna Vihola, Jaakko Sarparanta, Bjarne Udd and 3 more

Abstract readCase Reports
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Milla LaarneFolkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland. milla.laarne@helsinki.fi.ORCID http://orcid.org/0000-0001-5690-4779
Manu JokelaClinical Neurosciences, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0002-7568-4684
Fang ZhaoDepartment of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID http://orcid.org/0000-0003-3057-8738
Sanna HuovinenDepartment of Pathology, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
Cornelia KornblumDepartment of Neuromuscular Diseases, Center for Neurology, University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0002-0111-7281
Jens ReimannDepartment of Neuromuscular Diseases, Center for Neurology, University Hospital Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0003-3349-6877
Mridul JohariHarry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, WA, Australia.ORCID http://orcid.org/0000-0002-3549-558X
Anna ViholaFolkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0001-9249-8480
Jaakko SarparantaFolkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0002-5497-5255
Bjarne UddFolkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.
Peter HackmanFolkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0001-7890-5713
Vilma-Lotta LehtokariFolkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0002-8276-0972
Katarina PelinFolkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.ORCID http://orcid.org/0000-0002-7040-7266

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVariants in CASQ1, encoding a calcium-binding protein in the fast-twitch fibers of skeletal muscle, cause sarcoplasmic reticulum aberrations such as large vacuoles with CASQ1 inclusions or, less commonly, tubular aggregates. To date, seven pathogenic variants have been described, all dominant missense variants. The typical symptoms of the disease include muscle weakness, cramps, myalgia, and fatigue.

methodsWe used genome and exome sequencing to identify the disease-causing variants in two families with dominant myopathy. The candidate variants were further characterized by cell-transfection studies and western blotting.

resultsIn Family 1, three patients presented with exercise intolerance, cramps, and myalgia. Additionally, the proband had muscle weakness and her muscle biopsy showed nemaline bodies. In electron microscopy, there were morphological changes in the triads and the SR-feet in all patients. A variant in CASQ1, p.(Glu89Lys), was found in all patients, whereas the proband had also two compound heterozygous variants in NEB. In Family 2, three patients presented with progressive muscle weakness. The proband's muscle biopsy showed marked atrophy. The frameshift variant p.(Gly383Alafs*39) in CASQ1 was found in all three patients. In silico analysis indicated that the variant results in protein extension, which was confirmed by western blotting of patient muscle. Cell-transfection studies showed that the variant protein forms aggregates.

conclusionThis study expands the spectrum of pathogenic CASQ1 variants. The morphological changes in the SR-feet indicate a novel pathogenetic mechanism.

Indexed as

Calcium-Binding ProteinsMuscular DiseasesAdultCalsequestrinFemaleHumansMaleMiddle AgedMuscle, SkeletalPedigreePhenotypeCalcium-Binding ProteinsCalsequestrinCASQ1 protein, humanCalsequestrin-1CASQ1MyopathySR-feet

Identifiers

PMID41313434
PMCPMC12662904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.